Flagship Biosciences and Leap Therapeutics (LPTX) announced a partnership to use a clinically validated tumor expression assay utilizing RNAscope and tissue image analysis. In a poster shared this week at the American Association for Cancer Research (AACR) Annual Meeting 2021, the companies presented data on the validation of a Dickkopf-1 (DKK1) RNAscope chromogenic in situ hybridization (CISH) assay and digital image analysis solution.
Plus (formerly Plus.ai), a leading global self-driving truck technology company, announced today that the company has signed a Memorandum of Understanding (MOU) with IVECO, a brand of CNH Industrial N.V. (CNHI) and a pioneer in the commercialization and manufacturing of vehicles powered by alternative fuels, to jointly develop autonomous trucks that will be deployed across Europe, China, and other geographies.
Twist Bioscience (TWST) will exercise its option to purchase all rights to a G-coupled protein receptor (GPCR) library and its proprietary Twist Antibody Optimization (TAO) software, both developed in collaboration with Distributed Bio.
Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.